These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38333641)

  • 1. [Retracted] LncRNA GAS6 antisense RNA 1 facilitates the tumorigenesis of clear cell renal cell carcinoma by regulating the AMP‑activated protein kinase/mTOR signaling pathway.
    Guo X; Li H; Zhang M; Li R
    Oncol Lett; 2024 Mar; 27(3):126. PubMed ID: 38333641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA GAS6 antisense RNA 1 facilitates the tumorigenesis of clear cell renal cell carcinoma by regulating the AMP-activated protein kinase/mTOR signaling pathway.
    Guo X; Li H; Zhang M; Li R
    Oncol Lett; 2021 Oct; 22(4):727. PubMed ID: 34429767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
    Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
    Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9859381. PubMed ID: 37811306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node metastasis-related lncRNA GAS6-AS1 facilitates the progression of esophageal squamous cell carcinoma.
    Xie Y; Zhang Z; Lai D; Liang J; Zhao Z; Lu W; Ke J; Lin W; He H
    J Gastrointest Oncol; 2023 Dec; 14(6):2293-2308. PubMed ID: 38196547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA GAS6-AS1 facilitates tumorigenesis and metastasis of colorectal cancer by regulating TRIM14 through miR-370-3p/miR-1296-5p and FUS.
    Chen Q; Zhou L; Ma D; Hou J; Lin Y; Wu J; Tao M
    J Transl Med; 2022 Aug; 20(1):356. PubMed ID: 35962353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retracted] lncRNA ST8SIA6‑AS1 facilitates proliferation and invasion in liver cancer by regulating miR‑142‑3p.
    Zhang Y; Yang Y; Zhang Y; Liu Z
    Exp Ther Med; 2024 Sep; 28(3):338. PubMed ID: 39006456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA GAS6-AS2 facilitates tumor growth and metastasis of hepatocellular carcinoma by activating the PI3K/AKT/FoxO3a signaling pathway.
    Liang C; Pang L; Ke Y; Ji W; Xiong J; Ding R; Ding Y
    Int J Clin Exp Pathol; 2019; 12(11):4011-4023. PubMed ID: 31933797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retracted] Long non‑coding RNA NEAT1 promotes the malignancy of laryngeal squamous cell carcinoma by regulating the microRNA‑204‑5p/SEMA4B axis.
    Han L; Zheng C; Wu S
    Oncol Lett; 2024 Jan; 27(1):15. PubMed ID: 38028178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA GA-Binding Protein Transcription Factor Subunit Beta-1 Antisense RNA 1 Inhibits Renal Carcinoma Growth Through an MiR-1246/Phosphoenolpyruvate Carboxykinase 1 Pathway [Retraction].
    Onco Targets Ther; 2022; 15():83-84. PubMed ID: 35087277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retracted] Long non‑coding RNA Igf2as controls hepatocellular carcinoma progression through the ERK/MAPK signaling pathway.
    Bao H; Guo CG; Qiu PC; Zhang XL; Dong Q; Wang YK
    Oncol Lett; 2024 Dec; 28(6):553. PubMed ID: 39345721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9792473. PubMed ID: 37947004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Landscape of prognostic signatures and immunogenomics of the AXL/GAS6 axis in renal cell carcinoma.
    Hakozaki K; Tanaka N; Takamatsu K; Takahashi R; Yasumizu Y; Mikami S; Shinojima T; Kakimi K; Kamatani T; Miya F; Tsunoda T; Aimono E; Nishihara H; Mizuno R; Oya M
    Br J Cancer; 2021 Nov; 125(11):1533-1543. PubMed ID: 34611307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USF1-mediated upregulation of lncRNA GAS6-AS2 facilitates osteosarcoma progression through miR-934/BCAT1 axis.
    Wei G; Zhang T; Li Z; Yu N; Xue X; Zhou D; Chen Y; Zhang L; Yao X; Ji G
    Aging (Albany NY); 2020 Apr; 12(7):6172-6190. PubMed ID: 32269179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA GAS6-AS2 promotes non-small-cell lung cancer cell proliferation via regulating miR-144-3p/ MAPK6 axis.
    Hou G; Yang J; Tang J; He Y
    Cell Cycle; 2021 Jan; 20(2):179-193. PubMed ID: 33459113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retracted] Effect of microRNA-27b on cisplatin chemotherapy sensitivity of oral squamous cell carcinoma via FZD7 signaling pathway.
    Liu B; Cao G; Dong Z; Guo T
    Oncol Lett; 2024 Jun; 27(6):275. PubMed ID: 38690102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Curcumin Inhibits the Proliferation of Renal Cancer 786-O Cells through MTOR Signaling Pathway and Its Mechanism.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9784315. PubMed ID: 37476781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: lncRNA MSC-AS1/miRNA-429 Axis Mediates Growth and Metastasis of Nasopharyngeal Carcinoma via JAK1/STAT3 Signaling Pathway.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9768312. PubMed ID: 38077908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Integrated Analysis of the Roles of RNA Binding Proteins and Their Prognostic Value in Clear Cell Renal Cell Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9828737. PubMed ID: 37266270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of lncRNA-HOTAIR downregulates the drug-resistance of breast cancer cells to doxorubicin via the PI3K/AKT/mTOR signaling pathway.
    Li Z; Qian J; Li J; Zhu C
    Exp Ther Med; 2019 Jul; 18(1):435-442. PubMed ID: 31281438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.